Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
A peer-reviewed randomized clinical trial published in JAMA Network Open reveals that a single synthetic dose of psilocybin significantly reduced cocaine consumption in adults with cocaine use disorder over a six-month period without serious adverse events. Filament Health Corp., wholly owned by Red Light Holland, hol…
Share This Article
Ready-to-post copy includes the article link.
Red Light Holland Spotlights JAMA Trial Demonstrating Single Psilocybin Dose Cuts Cocaine Use Over Six Months A peer-reviewed randomized clinical trial published in JAMA Network Open reveals that a single synthetic dose of psilocybin significantly reduced cocaine consumption in adults with cocaine use disorder over a six-month... Read the full IIPLA article: https://iipla.org/news/red-light-holland-spotlights-jama-trial-demonstrating-single-psilocybin-dose-cuts-cocaine-use-over-six-months